APA (7th ed.) Citation

Zhang, Q., Zhang, Q., Yang, L., Yang, S., & Lu, Y. (2024). Renal, cardiovascular, and safety outcomes of adding sodium–glucose cotransporter-2 inhibitors to insulin therapy in patients with type-2 diabetes: A meta-analysis. International urology and nephrology, 56(2), 557-570. https://doi.org/10.1007/s11255-023-03719-6

Chicago Style (17th ed.) Citation

Zhang, Qian, Qingqing Zhang, Liu Yang, Shufang Yang, and Yu Lu. "Renal, Cardiovascular, and Safety Outcomes of Adding Sodium–glucose Cotransporter-2 Inhibitors to Insulin Therapy in Patients with Type-2 Diabetes: A Meta-analysis." International Urology and Nephrology 56, no. 2 (2024): 557-570. https://doi.org/10.1007/s11255-023-03719-6.

MLA (9th ed.) Citation

Zhang, Qian, et al. "Renal, Cardiovascular, and Safety Outcomes of Adding Sodium–glucose Cotransporter-2 Inhibitors to Insulin Therapy in Patients with Type-2 Diabetes: A Meta-analysis." International Urology and Nephrology, vol. 56, no. 2, 2024, pp. 557-570, https://doi.org/10.1007/s11255-023-03719-6.